These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28771275)

  • 1. Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved.
    Jendroszek A; Sønnichsen MS; Muñoz AC; Leyman K; Christensen A; Petersen SV; Wang T; Bendixen C; Panitz F; Andreasen PA; Jensen JK
    Thromb Haemost; 2017 Aug; 117(9):1688-1699. PubMed ID: 28771275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of plasminogen activator inhibitor-1.
    Wind T; Jensen JK; Dupont DM; Kulig P; Andreasen PA
    Eur J Biochem; 2003 Apr; 270(8):1680-8. PubMed ID: 12694181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
    Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M; Busse MN; Andreasen PA
    Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
    Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
    Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein conformational change delayed by steric hindrance from an N-linked glycan.
    Bager R; Johansen JS; Jensen JK; Stensballe A; Jendroszek A; Buxbom L; Sørensen HP; Andreasen PA
    J Mol Biol; 2013 Aug; 425(16):2867-77. PubMed ID: 23702291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
    Kirkegaard T; Jensen S; Schousboe SL; Petersen HH; Egelund R; Andreasen PA; Rodenburg KW
    Eur J Biochem; 1999 Jul; 263(2):577-86. PubMed ID: 10406969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.
    Qureshi T; Peterson CB
    Protein Sci; 2016 Feb; 25(2):487-98. PubMed ID: 26540464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
    Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
    Pedersen KE; Einholm AP; Christensen A; Schack L; Wind T; Kenney JM; Andreasen PA
    Biochem J; 2003 Jun; 372(Pt 3):747-55. PubMed ID: 12656676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper(II) Ions Increase Plasminogen Activator Inhibitor Type 1 Dynamics in Key Structural Regions That Govern Stability.
    Bucci JC; Trelle MB; McClintock CS; Qureshi T; Jørgensen TJ; Peterson CB
    Biochemistry; 2016 Aug; 55(31):4386-98. PubMed ID: 27416303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
    Gils A; Knockaert I; Declerck PJ
    Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interactions of serpins in their native forms attenuate their conformational transitions.
    Na YR; Im H
    Protein Sci; 2007 Aug; 16(8):1659-66. PubMed ID: 17600149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.
    Na YR; Im H
    Protein Sci; 2005 Jan; 14(1):55-63. PubMed ID: 15576554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural factors affecting the choice between latency transition and polymerization in inhibitory serpins.
    Yi JY; Im H
    Protein Sci; 2007 May; 16(5):833-41. PubMed ID: 17400919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition.
    Haynes LM; Huttinger ZM; Yee A; Kretz CA; Siemieniak DR; Lawrence DA; Ginsburg D
    J Biol Chem; 2022 Dec; 298(12):102608. PubMed ID: 36257408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of beta-strand 5A of plasminogen activator inhibitor-1 in regulation of its latency transition and inhibitory activity by vitronectin.
    Jensen S; Kirkegaard T; Pedersen KE; Busse M; Preissner KT; Rodenburg KW; Andreasen PA
    Biochim Biophys Acta; 2002 Jun; 1597(2):301-10. PubMed ID: 12044908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.